Launching soon! Yposkesi's Plug & Play Robust and Scalable, Lentivirus Manufacturing Platform
Official launch on April 5th!
With an increasing number of cell therapies entering pre-clinical and clinical trials, the demand for lentivirus manufacturing is higher than ever, and with this the need for safe and efficient lentivirus manufacturing.
Yposkesi will be launching soon a lentivirus manufacturing platform, dedicated to accelerate the time to market of your cell and gene therapies and facilitate better patient outcomes.
Yposkesi’s new large-scale lentivirus manufacturing platform provides the premium quality grade lentiviral vectors you need to assure your clinical development and commercial cell and gene therapy pipeline.
Subscribe to our newsletter and follow us on LinkedIn to know more about our new lentivirus platform on April 5th:
Can you guess the new name of the platform? A hint is hidden on this page, if you find it, contact us at email@example.com!
Your Sherlock Holmes’ mind will be rewarded!